Truist Financial’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-12,000
Closed -$5K 874
2016
Q3
$5K Hold
12,000
﹤0.01% 833
2016
Q2
$16K Sell
12,000
-10
-0.1% -$16 ﹤0.01% 851
2016
Q1
$16K Hold
12,010
﹤0.01% 792
2015
Q4
$17K Hold
12,010
﹤0.01% 777
2015
Q3
$19K Hold
12,010
﹤0.01% 816
2015
Q2
$20K Hold
12,010
﹤0.01% 809
2015
Q1
$26K Hold
12,010
﹤0.01% 792
2014
Q4
$16K Hold
12,010
﹤0.01% 790
2014
Q3
$10K Hold
12,010
﹤0.01% 755
2014
Q2
$27K Hold
12,010
﹤0.01% 780
2014
Q1
$36K Hold
12,010
﹤0.01% 785
2013
Q4
$38K Hold
12,010
﹤0.01% 774
2013
Q3
$33K Hold
12,010
﹤0.01% 733
2013
Q2
$30K Buy
+12,010
New +$63K ﹤0.01% 731

Other funds holding ECTE

Truist Financial's ECTE Position: Q4 2016 in Review

Truist Financial sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q4 2016, closing a stake of 12,000 shares — an estimated $5K sold.

Truist Financial first reported a position in ECTE in Q2 2013 and held it in 14 quarters. The position peaked at $38K in Q4 2013. 2 funds tracked by Wall St. Rank hold ECTE as of Q4 2016.

  • Truist Financial reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q4 2016 after selling out during the quarter.
  • Truist Financial sold 12,000 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q4 2016, an estimated $5K.
  • Truist Financial first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 14 quarters.
  • Truist Financial's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $38K in Q4 2013.
  • 2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q4 2016.

Based on Truist Financial's 13F filing for Q4 2016, filed 2 Feb 2017.